银屑病
炎症
树突状细胞
下调和上调
癌症研究
免疫学
医学
细胞生物学
促炎细胞因子
脂质代谢
化学
T细胞
细胞
生物
功能(生物学)
免疫疗法
治疗方法
脂质信号
新陈代谢
作者
Ai-Ping Cao,Juncheng Li,Rui Wang,Yunying Wang,Nan Wu,Yan-Hong Liu,Zhi Jin,Jiayu Liu,Yanyan Shen,Yue Guo,Qi Qi,Yao Wang,Ruibo Wang,Boyang Xie,Chun-Yan Yan,Qiuying Han,Shaoyi Huang,Sheng‐Ming Wu,Na Wang,Xin Pan
摘要
Aberrant activation of dendritic cells (DCs) is intricately associated with inflammatory diseases, rendering DCs an appealing therapeutic target. Metabolites are emerging as crucial regulators of DCs, yet therapeutic strategies targeting DC metabolism for inflammatory diseases remain underexplored. Our study identifies the Vanin-pantethine-cholesterol axis as a key metabolic pathway that governs DC activation-a classical APC function. We found that Vanin is upregulated in activated DCs from autoimmune patients and mice; DC-specific Vanin deficiency significantly alleviates psoriasiform inflammation in mice. Mechanistically, Vanin hydrolyzes pantethine, leading to cholesterol and lipid raft accumulation on the cell membrane and promoting DC hyperactivation. Pantethine supplementation or pharmacologically induced Vanin inhibition reduces cholesterol overload, impedes DC activation, and mitigates psoriasiform inflammation. Notably, pantethine or RR6 treatment impairs activation of patient-derived DCs, and our investigator-initiated trial shows that pantethine combination therapy relieves clinical symptoms in psoriasis patients. Collectively, these findings establish the Vanin-pantethine-cholesterol axis as a key modulator of APC function, offering a promising metabolic approach for inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI